Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Sprout Social Shares Plunge to New Lows Amid Insider Selling and Analyst Downgrades

Felix Baarz by Felix Baarz
November 1, 2025
in Analysis, Nasdaq, Tech & Software, Trading & Momentum
0
Sprout Social Stock
0
SHARES
11
VIEWS
Share on FacebookShare on Twitter

Sprout Social stock continues its dramatic descent, touching fresh 52-week lows during Thursday’s trading session. The equity plummeted to $10.30 before settling at $10.34 by market close, with trading volume surging significantly. One market report noted the shares briefly touched $9.99 at their lowest point. Over the past twelve months, investors have watched the stock erase 70.74% of its value.

Institutional Activity and Market Valuation

Despite the severe price decline, institutional ownership remains at 100%, with Jennison Associates increasing its stake by 8.7% during the second quarter. The company’s market capitalization currently fluctuates between $589 million and $613 million. This institutional confidence contrasts sharply with recent insider behavior and analyst sentiment.

Widespread Analyst Pessimism

Market experts maintain a cautious “Hold” consensus rating, but several firms have substantially reduced their price targets. Oppenheimer slashed its target from $32 to $23, while Canaccord Genuity lowered its projection from $30 to $25. Weiss Ratings took a more drastic stance, issuing a “Sell” recommendation in October. The wide dispersion of price targets—ranging from $17 to $32—highlights substantial uncertainty about the company’s direction.

Should investors sell immediately? Or is it worth buying Sprout Social?

Insider Transactions Raise Concerns

Corporate insiders have been rapidly reducing their positions, adding to the negative momentum. On October 7, one insider disposed of 20,000 shares at an average price of $11.81, cutting their holding by nearly 73%. Over the past ninety days, company insiders have collectively sold 50,566 shares valued at $695,181, signaling deep concern among those most familiar with the company’s prospects.

Financial Health Presents Mixed Picture

The upcoming quarterly report on November 5 represents a critical juncture for the struggling social media management platform. Current financial metrics reveal contradictory signals:

  • Negative price-to-earnings ratio and -25.85% return on equity
  • Debt-to-equity ratio stands at -0.48%
  • Positive free cash flow exceeding $86 million
  • Previous quarter delivered $0.18 EPS on $111.78 million revenue
  • Next quarter projections anticipate a loss of $0.22 per share

Turning Point Ahead

All attention now focuses on whether the acquisition of NewsWhip and growing demand for social media management solutions can reverse the downward trajectory. The November 5 earnings release will determine if Sprout Social can stabilize its performance or face continued pressure from both Wall Street and its own leadership team.

Ad

Sprout Social Stock: Buy or Sell?! New Sprout Social Analysis from February 7 delivers the answer:

The latest Sprout Social figures speak for themselves: Urgent action needed for Sprout Social investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Sprout Social: Buy or sell? Read more here...

Tags: Sprout Social
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

CrossFirst Bankshares Stock
Analysis

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Myers Industries Stock
Analysis

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
OneSpan Stock
Cyber Security

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026
Next Post
Potbelly Stock

Potbelly's Public Market Journey Concludes Following RaceTrac Acquisition

Cooper-Standard Stock

Cooper-Standard Shares Plunge on Disappointing Earnings Report

Flushing Stock

Flushing Financial Delivers Stellar Third Quarter Performance

Recommended

Super Micro Computer Stock

Super Micro Stock Surges Amid AI Infrastructure Boom

4 months ago
Adobe Stock

Adobe’s AI Ambitions Face Investor Skepticism

4 months ago
IBM Stock

Strong IBM Earnings Fail to Impress Market as Key Segment Shows Weakness

4 months ago
Inozyme Pharma Inc Stock

Inozyme Pharma Acquisition Finalized: Strategic Focus Shifts to Clinical Development

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Investors Await March Report for Boston Omaha’s Strategic Direction

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

Trending

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

by Rodolfo Hanigan
February 7, 2026
0

Investor attention turns to Orthofix Medical as the company bolsters the clinical support for its biologics business...

CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
OneSpan Stock

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio
  • A New Chapter for First Busey as CrossFirst Merger Finalizes
  • Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com